SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-052052
Filing Date
2023-10-04
Accepted
2023-10-04 20:33:48
Documents
1
Period of Report
2023-10-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 9451
  Complete submission text file 0000950170-23-052052.txt   10844
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Issuer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AKERO THERAPEUTICS, INC. 170 HARBOR WAY 3RD FL SOUTH SAN FRANCISCO CA 94080
Business Address
Young Jonathan (Reporting) CIK: 0001779805 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38944 | Film No.: 231309584